ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.455
-0.205 (-12.35%)
At close: Oct 24, 2024, 4:00 PM
1.460
+0.005 (0.34%)
After-hours: Oct 24, 2024, 4:39 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $76.64 million as of October 24, 2024. Its market cap has decreased by -80.44% in one year.
Market Cap
76.64M
Enterprise Value
-51.82M
1-Year Change
-80.44%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.04B to $76.64M, a decrease of -92.64%. That is a compound annual growth rate of -45.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 87.40M | -88.22% |
| Dec 29, 2023 | 741.80M | 61.51% |
| Dec 30, 2022 | 459.30M | -47.23% |
| Dec 31, 2021 | 870.30M | -72.79% |
| Dec 31, 2020 | 3.20B | 207.18% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 83.52M |
| Ikena Oncology | 81.56M |
| IO Biotech | 81.03M |
| Cidara Therapeutics | 80.10M |
| Aileron Therapeutics | 79.51M |
| Monogram Technologies | 78.94M |
| Chimerix | 78.54M |
| Protalix BioTherapeutics | 77.96M |